Dexcom G5 Mobile
Device Name:
G5 Mobile
Manufacturer:
Dexcom, 6340 Sequence Dr, San Diego, CA 92121, UNITED STATES.
Measuring functions:
Blood glucose
Primary Client Use:
Intended for both professional use and self-measurement
Measurement Site:
Abdomen
Measurement Occurrence:
Continuous measurement
Availability:
Available Currently
Device Manual:
Click here to download the Device Manual
Description:
The Dexcom G5 Mobile is a mobile (floor, stand, trolly) automatic blood glucose meter. Medaval has not found evidence proving the accuracy of its blood glucose measurement technology. Blood glucose measurements are taken from the abdomen. It is intended for both professional use and self-measurement.
Assessment:
There appears to be no peer-reviewed clinical validation information available on the technology used in the Dexcom G5 Mobile to measure blood glucose.
Recommendations:
Accuracy AssessmentRecommendationBasis
BG Medaval Not recommended This device has not been clinically validated.
Relevant Publications:

Vandersluis S, Kabali C, Djalalov S, Gajic-Veljanoski O, Wells D and Holubowich C on behalf of Health Quality Ontario. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment. Ont Health Technol Assess Ser. 2018 Feb 21;18(2):1-160. PMID: 29541282. Available from: PMC5836597. eCollection 2018.

The publication describes the use of the Dexcom G4 Platinum in a scientific study.

Freckmann G, Link M, Pleus S, Westhoff A, Kamecke U, Haug C. Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose Monitoring. J Diabetes Sci Technol. 2018 Aug;20(8):541-549. doi: 10.1089/dia.2018.0105. PMID: 30067410. Available from: PMC6080122.

The publication evaluates the performance of the Dexcom G5 Mobile, though not in a formal validation.

Approximately 25% of results showed differences from reference results exceeding 15 mg/dL, at glucose concentration below 100 mg/dL, or exceeding 15%, at glucose concentration above 100 mg/dL, at times of therapeutic decisions.

Ólafsdóttir AF, Andelin M, Saeed A, Sofizadeh S, Hamoodi H, Jansson PA, Lind M. Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease. World J Clin Cases. 2022 Aug 6;10(22):7794-7807. doi: 10.12998/wjcc.v10.i22.7794. PMID: 36158498. Available from: PMC9372866.

Measurements from the Dexcom G5 Mobile are compared to those from HemoCue Glucose 201 DM RT, though not in a formal validation.

The Dexcom G5 had a similar accuracy in people with diabetes and advanced CKD as in people with diabetes without advanced CKD.

© Medaval Ltd. Please read the Terms and Conditions before using this site.